Zurloh, M.
Goetz, M.
Herold, T.
Treckmann, J.
Markus, P.
Schumacher, B.
Albers, D.
Rink, A.
Rosery, V.
Zaun, G.
Kostbade, K.
Pogorzelski, M.
Ting, S.
Schmidt, H.
Stiens, R.
Wiesweg, M.
Schuler, M.
Kasper, Stefan
Virchow, I.
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 5 July 2023
Accepted: 6 July 2023
First Online: 19 July 2023
Declarations
:
: Martin Schuler received honoraria as consultant (compensated) from Amgen, AstraZeneca, BIOCAD, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Merck Serono, Novartis, Roche, Sanofi, Takeda, Honoraries for CME presentations from Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Novartis and Research funding to institution from AstraZeneca, Bristol Myers-Squibb Stefan Kasper received honoraria from Merck Serono, MSD, Novartis, BMS, Amgen, Roche, Sanofi-Aventis, Servier, Incyte, Pierre Fabre and Lilly; research funding from Merck Serono, Lilly, BMS, Roche. Isabel Virchow received travel support from Pierre Fabre. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: MS received honoraria as consultant (compensated) from Amgen, AstraZeneca, BIOCAD, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Merck Serono, Novartis, Roche, Sanofi, Takeda, Honoraries for CME presentations from Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Novartis and Research funding to institution from AstraZeneca, Bristol Myers-Squibb. SK received honoraria from Merck Serono, MSD, Novartis, BMS, Amgen, Roche, Sanofi-Aventis, Servier, Incyte, Pierre Fabre and Lilly; research funding from Merck Serono, Lilly, BMS, Roche. IV received travel support from Pierre Fabre. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.